Skip to main content

Brain Metastases: Treatment with Stereotactic Iodine-125 Brachytherapy

  • Chapter
  • First Online:
Tumors of the Central Nervous System, Volume 11

Part of the book series: Tumors of the Central Nervous System ((TCNS,volume 11))

  • 1297 Accesses

Abstract

The treatment modalities for brain metastases include, in general, stereotactic radiosurgery (SRS) and/or micro-neurosurgical resection combined with external beam radiation therapy (EBRT) as well as whole brain radiation therapy (WBRT) for multiple cerebral tumors. Presently, stereotactic brachytherapy (SBT) is successfully used for the treatment of well circumscribed (low grade) glial tumors, but can also be applied for the treatment of brain metastases. Especially in cases where histological confirmation is requested SBT can be combined with stereotactic biopsy within one minimal invasive and safe surgical procedure. Due to the favorable radiobiology of low dose rate irradiation and a steep dose fall-off from the irradiation center within the tumor towards the periphery SBT represents a highly localized treatment option for not restricting later EBRT/WBRT, not increasing the risk of adverse irradiation effects when applied in case of local tumor recurrence after previous SRS/EBRT treatment, and for tumors >3 cm in diameter. It also has been demonstrated that the overall survival and local control rates are comparable to those after SRS treatment. Thus, SBT is a safe, effective, and minimal invasive local treatment option for selected patients with a single brain metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alesch F, Hawliczek R, Koos WT (1995) Interstitial irradiation of brain metastases. Acta Neurochir Suppl 63:29–34

    PubMed  CAS  Google Scholar 

  • Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491

    Article  PubMed  CAS  Google Scholar 

  • Baumert BG, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx MJ, Debougnoux-Huppertz RM, Lambin P, Kubat B (2006) A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 66:187–194

    Article  PubMed  Google Scholar 

  • Bernstein M, Cabantog A, Laperriere N, Leung P, Thomason C (1995) Brachytherapy for recurrent single brain metastasis. Can J Neurol Sci 22:13–16

    PubMed  CAS  Google Scholar 

  • Bogart JA, Ungureanu C, Shihadeh E, Chung TC, King GA, Ryu S, Kent C, Winfield JA (1999) Resection and permanent I-125 brachytherapy without whole brain irradiation for solitary brain metastasis from non-small cell lung carcinoma. J Neurooncol 44:53–57

    Article  PubMed  CAS  Google Scholar 

  • Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044

    Article  PubMed  Google Scholar 

  • Chao JH, Phillips R, Nickson JJ (1954) Roentgen-ray therapy of cerebral metastases. Cancer 7:682–689

    Article  PubMed  CAS  Google Scholar 

  • Dagnew E, Kanski J, McDermott MW, Sneed PK, McPherson C, Breneman JC, Warnick RE (2007) Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience. Neurosurg Focus 22:E3

    PubMed  Google Scholar 

  • Danlos H (1905) Quelques considerations sur le traitement des dermatoses par le radium. J Physiother (Paris) 3:98–106

    Google Scholar 

  • Frazier CH (1920) The effects of radium emanations upon brain tumors. Surg Gynecol Obstet 31:236–239

    Google Scholar 

  • Gutin PH, Phillips TL, Wara WM, Leibel SA, Hosobuchi Y, Levin VA, Weaver KA, Lamb S (1984) Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources. J Neurosurg 60:61–68

    Article  PubMed  CAS  Google Scholar 

  • Heintz BH, Wallace RE, Hevezi JM (2001) Comparison of I-125 sources used for permanent interstitial implants. Med Phys 28:671–682

    Article  PubMed  CAS  Google Scholar 

  • Hirsch O (1912) Die operative Behandlung von Hypophysentumoren: Nach endonasalen Methoden. Arch Laryngol Rhinol 26:529–686

    Google Scholar 

  • Hoefnagels FW, Lagerwaard FJ, Sanchez E, Haasbeek CJ, Knol DL, Slotman BJ, Vandertop WP (2009) Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol 256:878–887

    Article  PubMed Central  PubMed  Google Scholar 

  • Huang K, Sneed PK, Kunwar S, Kragten A, Larson DA, Berger MS, Chan A, Pouliot J, McDermott MW (2009) Surgical resection and permanent iodine-125 brachytherapy for brain metastases. J Neurooncol 91:83–93

    Article  PubMed  CAS  Google Scholar 

  • Hubbell JH, Seltzer SM (1995) Tables of X-ray mass attenuation coefficients and mass energy-absorption coefficients 1 keV to 20 MeV for elements Z = 1 to 92 and 48 additional substances of dosimetric interest. Technical report NISTIR 5632, NIST, Gaithersburg, MD 20899

    Google Scholar 

  • Huber PE, Hawighorst H, Fuss M, van Kaick G, Wannenmacher MF, Debus J (2001) Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 49:1339–1349

    Article  PubMed  CAS  Google Scholar 

  • Hunsche S, Sauner D, Maarouf M, Poggenborg J, Lackner K, Sturm V, Treuer H (2009) Intraoperative X-ray detection and MRI-based quantification of brain shift effects subsequent to implantation of the first electrode in bilateral implantation of deep brain stimulation electrodes. Stereotact Funct Neurosurg 87:322–329

    Article  PubMed  Google Scholar 

  • Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29:134–141

    Article  PubMed Central  PubMed  Google Scholar 

  • Kofman S, Garvin JS, Nagamani D, Taylor SG (1957) Treatment of cerebral metastases from breast carcinoma with prednisolone. J Am Med Assoc 163:1473–1476

    Article  PubMed  CAS  Google Scholar 

  • Kreth F, Faist M, Grau S, Ostertag C (2006) Interstitial 125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adults: long-term results and prognostic factors. Cancer 106:1372–1381

    Article  PubMed  Google Scholar 

  • Laperriere NJ, Leung PM, McKenzie S, Milosevic M, Wong S, Glen J, Pintilie M, Bernstein M (1998) Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41:1005–1011

    Article  PubMed  CAS  Google Scholar 

  • Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277–1280

    PubMed  CAS  Google Scholar 

  • Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, Kreth FW (2008) Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 87:299–307

    Article  PubMed  Google Scholar 

  • Mundinger F (1956) Eine einfache Methode der lokalisierten Bestrahlung von Großhirngschwülsten mit radioaktivem Gold. Münch Med Wschr 98:23–25

    PubMed  CAS  Google Scholar 

  • Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS (1995) Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 22:209–234

    Article  PubMed  CAS  Google Scholar 

  • Ostertag CB, Kreth FW (1995) Interstitial iodine-125 radiosurgery for cerebral metastases. Br J Neurosurg 9:593–603

    Article  PubMed  CAS  Google Scholar 

  • Petr MJ, McPherson CM, Breneman JC, Warnick RE (2009) Management of newly diagnosed single brain metastasis with surgical resection and permanent I-125 seeds without upfront whole brain radiotherapy. J Neurooncol 92:393–400

    Article  PubMed  Google Scholar 

  • Prados M, Leibel S, Barnett CM, Gutin P (1989) Interstitial brachytherapy for metastatic brain tumors. Cancer 63:657–660

    Article  PubMed  CAS  Google Scholar 

  • Rogers LR, Rock JP, Sills AK, Vogelbaum MA, Suh JH, Ellis TL, Stieber VW, Asher AL, Fraser RW, Billingsley JS, Lewis P, Schellingerhout D, Shaw EG (2006) Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases. J Neurosurg 105:375–384

    Article  PubMed  Google Scholar 

  • Ruge MI, Kickingereder P, Grau S, Hoevels M, Treuer H, Sturm V (2011a) Stereotactic biopsy combined with stereotactic (125)iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases. J Neurooncol 105:109–118

    Article  PubMed  Google Scholar 

  • Ruge MI, Kocher M, Maarouf M, Hamisch C, Treuer H, Voges J, Sturm V (2011b) Comparison of stereotactic brachytherapy (125 iodine seeds) with stereotactic radiosurgery (LINAC) for the treatment of singular cerebral metastases. Strahlenther Onkol 187:7–14

    Article  PubMed  Google Scholar 

  • Ruge MI, Simon T, Suchorska B, Lehrke R, Hamisch C, Koerber F, Maarouf M, Treuer H, Berthold F, Sturm V, Voges J (2011c) Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome. J Clin Oncol 29:4151–4159

    Article  PubMed  Google Scholar 

  • Ruge MI, Suchorska B, Maarouf M, Runge M, Treuer H, Voges J, Sturm V (2011d) Stereotactic 125Iodine brachytherapy for the treatment of singular brain metastases: closing a gap? Neurosurgery 68:1209–1219

    PubMed  Google Scholar 

  • Schulder M, Black PM, Shrieve DC, Alexander E 3rd, Loeffler JS (1997) Permanent low-activity iodine-125 implants for cerebral metastases. J Neurooncol 33:213–221

    Article  PubMed  CAS  Google Scholar 

  • Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC, Malkin MG, Mealey JJ Jr, Neal JH, Olson J, Robertson JT, Barnett GH, Bloomfield S, Albright R, Hochberg FH, Hiesiger E, Green S (2002) The Brain Tumor Cooperative Group NIH Trial 87–01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51:343–355; discussion 355–347

    PubMed  Google Scholar 

  • Talairach J, Ruggiero G, Aboulker J, David M (1955) A new method of treatment of inoperable brain tumours by stereotaxic implantation of radioactive gold; a preliminary report. Br J Radiol 28:62–74

    Article  PubMed  CAS  Google Scholar 

  • Treuer H, Hunsche S, Hoevels M, Luyken K, Maarouf M, Voges J, Sturm V (2004) The influence of head frame distortions on stereotactic localization and targeting. Phys Med Biol 49:3877–3887

    Article  PubMed  CAS  Google Scholar 

  • Treuer H, Klein D, Maarouf M, Lehrke R, Voges J, Sturm V (2005) Accuracy and conformity of stereotactically guided interstitial brain tumour therapy using I-125 seeds. Radiother Oncol 77:202–209

    Article  PubMed  Google Scholar 

  • Viola A, Major T, Julow J (2006) Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy. Radiat Res 165:695–702

    Article  PubMed  CAS  Google Scholar 

  • Williamson JF, Butler W, Dewerd LA, Huq MS, Ibbott GS, Mitch MG, Nath R, Rivard MJ, Todor D (2005) Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy. Med Phys 32:1424–1439

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maximilian I. Ruge .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Ruge, M.I., Kickingereder, P., Treuer, H. (2014). Brain Metastases: Treatment with Stereotactic Iodine-125 Brachytherapy. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 11. Tumors of the Central Nervous System, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7037-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-7037-9_16

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-7036-2

  • Online ISBN: 978-94-007-7037-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics